In Texas, the death rate per capita of this disease is much higher than the national average. We'll explain who's at risk and ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

As winter sets in, there has been a noticeable rise in Pakistani citizens respiratory illnesses over the past few weeks.

Patients with early breast cancer who are older may experience high-grade immune-related side effects after receiving immune ...

Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5’ solid tumor strategy 18 months ahead of original ...

Metro Atlanta sees a rise in human parvovirus B-19 cases, especially affecting vulnerable groups like children with sickle ...

At highest risk are adults ages 75 and older, adults with chronic heart or lung disease, adults with weakened immune systems and adults with underlying medical conditions, such as diabetes or obesity.

Take this quiz to help determine if you may qualify for this minimally invasive procedure to treat severe emphysema or COPD. Please confirm diagnois. Emphysema is a chronic lung disease, which is ...

Cutting early life exposure to parental smoking may lower the risk of developing MS (multiple sclerosis) in those who are ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...